Breaking News Instant updates and real-time market news.

LVGO

Livongo Health

$37.00

3.22 (9.53%)

07:20
08/19/19
08/19
07:20
08/19/19
07:20

Livongo Health initiated with a Buy at Goldman Sachs

Goldman Sachs analyst Robert Joness initiated Livongo Health with a Buy and $43 price target saying its digital platform for managing chronic conditions is a compelling value proposition. The analyst sees share upside from the large addressable market and strong operating momentum.

  • 05

    Sep

LVGO Livongo Health
$37.00

3.22 (9.53%)

08/19/19
PIPR
08/19/19
INITIATION
Target $40
PIPR
Overweight
Livongo Health initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Sean Wieland initiated Livongo Health with an Overweight rating and a price target of $40, citing the ability of its platform to leverage AI to improve the lives of people suffering from chronic disease. The analyst notes that chronic disease accounts for about 90% of U.S. healthcare spending, and the company's estimate of total addressable market of $50B is likely conservative since it only accounts for 2 of the 4 conditions currently addressed by Livongo's marketed products.
08/19/19
LEER
08/19/19
INITIATION
Target $50
LEER
Outperform
Livongo Health initiated with an Outperform at SVB Leerink
SVB Leerink analyst Daniel Grosslight initiated Livongo Health with an Outperform and $50 price target.
08/19/19
NEED
08/19/19
INITIATION
Target $42
NEED
Buy
Livongo Health initiated with a Buy at Needham
Needham analyst Scott Berg initiated Livongo with a Buy rating and a price target of $42, saying that while the stock is not cheap at 13.5-times expected FY20 revenues, the valuation is still attractive given its multi-year 70% growth opportunity relative to fast-growth SaaS peers. The analyst notes the company's AI platform has produced "demonstrable" results for diabetes and hypertension patients, offering "compelling " solutions in terms of financial and quality-of-life considerations.
08/19/19
KEYB
08/19/19
INITIATION
Target $46
KEYB
Overweight
Livongo Health initiated with an Overweight at KeyBanc
KeyBanc analyst Donald Hooker started coverage of Livongo Health with an Overweight rating and a $46 price target. By his models, Livongo is set up to more than double its revenues in 2019, on an organic basis, with revenue growth of 70%-plus and 60%-plus in 2020 and 2021, respectively. The analyst also notes that the company generates consistently high, SaaS-like gross margins and economies of scale.

TODAY'S FREE FLY STORIES

RAD

Rite Aid

$7.30

0.4 (5.80%)

15:05
09/19/19
09/19
15:05
09/19/19
15:05
Options
Rite Aid call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SQ

Square

$58.77

-0.94 (-1.57%)

, LC

LendingClub

$14.60

-0.105 (-0.71%)

15:00
09/19/19
09/19
15:00
09/19/19
15:00
Periodicals
Fintech firm Stripe gets $35B valuation with latest funding round, WSJ reports »

Fintech company Stripe…

SQ

Square

$58.77

-0.94 (-1.57%)

LC

LendingClub

$14.60

-0.105 (-0.71%)

FISV

Fiserv

$105.34

1.14 (1.09%)

PYPL

PayPal

$106.02

0.42 (0.40%)

FNTE

FinTech Acquisition

$0.00

(0.00%)

BABA

Alibaba

$181.85

1.81 (1.01%)

LX

LexinFintech

$11.40

0.15 (1.33%)

ADYYF

Adyen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 27

    Oct

  • 06

    Nov

GDOT

Green Dot

$27.48

0.19 (0.70%)

14:55
09/19/19
09/19
14:55
09/19/19
14:55
Conference/Events
Green Dot participates in a conference call with SunTrust »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

STXS

Stereotaxis

$4.07

-0.27 (-6.22%)

14:52
09/19/19
09/19
14:52
09/19/19
14:52
Syndicate
Breaking Syndicate news story on Stereotaxis »

Stereotaxis files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$15.77

-0.52 (-3.19%)

14:43
09/19/19
09/19
14:43
09/19/19
14:43
Periodicals
Macy's to offer free same-day delivery for a limited time, Retail Dive reports »

Macy's has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TTEC

TTEC Holdings

$49.79

0.24 (0.48%)

14:41
09/19/19
09/19
14:41
09/19/19
14:41
Initiation
TTEC Holdings initiated  »

TTEC Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

IRBT

iRobot

$61.87

-0.58 (-0.93%)

14:35
09/19/19
09/19
14:35
09/19/19
14:35
Options
iRobot put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CNNE

Cannae Holdings

$26.72

-0.02 (-0.07%)

14:32
09/19/19
09/19
14:32
09/19/19
14:32
Hot Stocks
Cannae Holdings announces three-year, 5M share repurchase program »

Cannae Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

TSL

Trina Solar

$0.00

(0.00%)

, CSIQ

Canadian Solar

$22.24

0.56 (2.58%)

14:28
09/19/19
09/19
14:28
09/19/19
14:28
Periodicals
Solar and wind power 'so cheap they're outgrowing subsidies,' Bloomberg says »

According to…

TSL

Trina Solar

$0.00

(0.00%)

CSIQ

Canadian Solar

$22.24

0.56 (2.58%)

SPWR

SunPower

$15.20

0.775 (5.37%)

FSLR

First Solar

$67.32

1.55 (2.36%)

JASO

JA Solar

$0.00

(0.00%)

YGE

Yingli Green Energy

$0.00

(0.00%)

SUNEQ

SunEdison

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
09/19/19
09/19
14:20
09/19/19
14:20
General news
Treasury Action: Treasuries are holding modest gains »

Treasury Action:…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/19/19
09/19
14:17
09/19/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/19/19
09/19
14:16
09/19/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGM

LogMeln

$68.03

-0.63 (-0.92%)

14:11
09/19/19
09/19
14:11
09/19/19
14:11
Periodicals
Breaking Periodicals news story on LogMeln »

LogMeln turns positive,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$42.86

-0.06 (-0.14%)

, VAR

Varian Medical

$115.91

-1.54 (-1.31%)

14:11
09/19/19
09/19
14:11
09/19/19
14:11
Hot Stocks
Boston Scientific required to divest certain assets to Varian regarding BTG buy »

Medical device company…

BSX

Boston Scientific

$42.86

-0.06 (-0.14%)

VAR

Varian Medical

$115.91

-1.54 (-1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 23

    Oct

  • 13

    Nov

LOGM

LogMeln

$68.03

-0.63 (-0.92%)

14:10
09/19/19
09/19
14:10
09/19/19
14:10
Periodicals
Dealreporter says LogMeln having informal talks on selling parts, Bloomberg says »

Bloomberg cites…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$9.47

0.085 (0.91%)

14:06
09/19/19
09/19
14:06
09/19/19
14:06
Periodicals
Nelson Peltz says GE CEO Larry Culp is 'fantastic,' Reuters reports »

Trian Partners'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HIIQ

Health Insurance Innovations

$22.37

1.59 (7.65%)

14:05
09/19/19
09/19
14:05
09/19/19
14:05
Options
Health Insurance Innovations call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 02

    Oct

STX

Seagate

$52.92

-3.82 (-6.73%)

13:59
09/19/19
09/19
13:59
09/19/19
13:59
Recommendations
Seagate analyst commentary  »

Seagate price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SPY

SPDR S&P 500 ETF Trust

$301.58

0.48 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

13:51
09/19/19
09/19
13:51
09/19/19
13:51
General news
Global Times' Xijin says China 'not as anxious to reach a deal' as U.S. thought »

Hu Xijin, editor-in-chief…

SPY

SPDR S&P 500 ETF Trust

$301.58

0.48 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$52.71

0.11 (0.21%)

13:48
09/19/19
09/19
13:48
09/19/19
13:48
Conference/Events
Aflac to host analyst briefing »

Financial Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

ZYNE

Zynerba

$8.19

-0.65 (-7.35%)

, GWPH

GW Pharmaceuticals

$134.90

-0.73 (-0.54%)

13:47
09/19/19
09/19
13:47
09/19/19
13:47
Recommendations
Zynerba, GW Pharmaceuticals analyst commentary  »

Zynerba selloff on…

ZYNE

Zynerba

$8.19

-0.65 (-7.35%)

GWPH

GW Pharmaceuticals

$134.90

-0.73 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 02

    Oct

13:40
09/19/19
09/19
13:40
09/19/19
13:40
General news
Treasury's $12 B 10-yer TIPS reopening was ok »

Treasury's $12 B…

WE

We Company

$0.00

(0.00%)

13:38
09/19/19
09/19
13:38
09/19/19
13:38
Periodicals
WeWork leaves sensitive documents exposed via 'weak' Wi-Fi, CNet reports »

WeWork's weak Wi-Fi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENS

EnerSys

$64.00

0.24 (0.38%)

13:34
09/19/19
09/19
13:34
09/19/19
13:34
Hot Stocks
EnerSys reports fire at Richmond, Kentucky production facility »

EnerSys reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 02

    Oct

  • 13

    Nov

  • 14

    Nov

EE

El Paso Electric

$66.83

0.13 (0.19%)

, JPM

JPMorgan

$120.02

0.25 (0.21%)

13:29
09/19/19
09/19
13:29
09/19/19
13:29
Hot Stocks
El Paso Electric investors approve deal to be acquired by IIF »

El Paso Electric Company…

EE

El Paso Electric

$66.83

0.13 (0.19%)

JPM

JPMorgan

$120.02

0.25 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 15

    Oct

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.